HHMI
MRNA icon

Howard Hughes Medical Institute’s Moderna MRNA Stock Holding History

Howard Hughes Medical Institute’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-75
Closed -$2.21K – 326
2025
Q4 		$2.21K Buy
75
+1
+1% +$27 ﹤0.01% 467
2025
Q3 		$1.91K Buy
74
+1
+1% +$28 ﹤0.01% 474
2025
Q2 		$2.01K Buy
+73
New +$1.92K ﹤0.01% 466

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Howard Hughes Medical Institute's MRNA Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Moderna (MRNA) in Q1 2026, closing a stake of 75 shares — an estimated $2.21K sold.

Howard Hughes Medical Institute first reported a position in MRNA in Q2 2025 and held it in 3 quarters. The position peaked at $2.21K in Q4 2025. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 75 Moderna shares in Q1 2026, an estimated $2.21K.
  • Howard Hughes Medical Institute first reported a position in Moderna in Q2 2025 and held it in 3 quarters.
  • Howard Hughes Medical Institute's Moderna position peaked at $2.21K in Q4 2025.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.